Gargling with povidone-iodine may reduce salivary viral load

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

Related Keywords

Osaka , Japan , , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Automation Industry Focus , Coronavirus Disease Covid 19 , Clinical Trial , Coronavirus , Efficacy , Athogen , Espiratory , Respiratory Virus , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Virus ,

© 2025 Vimarsana